Data from EMC - Curated by Toby Galbraith - Last updated 17 March 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL) in adult patients.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)


Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

Visit Prostate Cancer


Related Content

More information

Category Value
Agency product number EMEA/H/C/002826
Orphan designation Yes
Date First Approved 03-03-2017
Type POM
Marketing authorisation holder Actelion Registration Ltd.